Clinical trial BGOG-cx1/ENGOT-cx1
Randomized double-blind phase II study comparing 3-weekly carboplatin (AUC 5 or 6) + paclitaxel 175 mg/m2 with or without concomitant and maintenance Nintedanib in advanced or recurrent cervical carcinoma
Cancers | |
---|---|
Organ | Uterus |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | BGOG |
EudraCT Identifier | 2012-004076-19 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02009579 |
Inclusion criteria | Second line |
Last update |